effect overlay
activetrials
Movement Disorders
Movement Disorders
Clinicodiagnostics in laryngeal movement disorders

Clinicodiagnostic features and treatment outcomes in laryngeal movement disorders
 

HREC: 2020.134
Principal Investigator: Dr Andrew Evans
Coordinator contact: Dr Belinda Cruse
Funding: Non-Commercial
Movement Disorders
Movement Disorders
M20 Advanced Parkinson's Disease

An Open-Label Extension of Studies M15-736 and M20-339 to Evaluate the Safety and Tolerability of 24-Hour Daily Exposure of ABBV-951 in Subjects with Advanced Parkinson's Disease
 

HREC: 2020.172
Principal Investigator: Dr Andrew Evans
Coordinator contact:
Funding: Commercial
Movement Disorders
Movement Disorders
ADROIT

DBS Registry of Outcomes for Indications over Time: Abbott's market-released DBS systems study
 

HREC: 2020.192
Principal Investigator: Dr Andrew Evans
Coordinator contact: Mr Girish Nair
Funding: Commercial
Movement Disorders
Movement Disorders
TEMPO4 Parkinson's Disease Study

58-Week Open-Label Trial of Tavapadon in Parkinson’s Disease
 

HREC: 2020.310
Principal Investigator: Dr Andrew Evans
Coordinator contact:
Funding: Commercial
Movement Disorders
Movement Disorders
PSP - SEL003

A Phase 2 Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Probable Progressive Supranuclear Palsy
 

HREC: 2020.317
Principal Investigator: Dr Andrew Evans
Coordinator contact:
Funding: Non-Commercial